CJC-1295 without DAC × Peak Peptides - Lab Test, February 2026
Test results
About this test
CJC-1295/Ipamorelin 10mg blend from Peak Peptides tested at 99.2% purity via UV/Vis spectrophotometry on February 7, 2026 by Analytical Formulations, Inc. The 1:1 ratio blend combines CJC-1295 with Ipamorelin for synergistic growth hormone secretagogue activity. The quantitative assay using Beer-Lambert methodology confirmed 10.96mg per vial against the 10mg label claim.
Heavy metals screening shows <20ppb combined metals, with total aerobic and yeast/mold microbial counts at 0 CFU/ml, indicating high manufacturing standards and sterile conditions.
The sample was received sealed and in good condition, with qualitative identification confirming both compounds match their characteristic reference standards.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.